Algethami, A.; Ahmed, A.M.A.; Ardah, H.; Alsalamah, S.; Alhabs, G.; Al Fraihi, G.; Alanazi, S.; Alharbi, H.; Aljizeeri, A.
Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis. Biomedicines 2025, 13, 490.
https://doi.org/10.3390/biomedicines13020490
AMA Style
Algethami A, Ahmed AMA, Ardah H, Alsalamah S, Alhabs G, Al Fraihi G, Alanazi S, Alharbi H, Aljizeeri A.
Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis. Biomedicines. 2025; 13(2):490.
https://doi.org/10.3390/biomedicines13020490
Chicago/Turabian Style
Algethami, Abdulaziz, Amjad M. A. Ahmed, Husam Ardah, Seham Alsalamah, Ghadah Alhabs, Ghadah Al Fraihi, Shahad Alanazi, Hend Alharbi, and Ahmed Aljizeeri.
2025. "Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis" Biomedicines 13, no. 2: 490.
https://doi.org/10.3390/biomedicines13020490
APA Style
Algethami, A., Ahmed, A. M. A., Ardah, H., Alsalamah, S., Alhabs, G., Al Fraihi, G., Alanazi, S., Alharbi, H., & Aljizeeri, A.
(2025). Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis. Biomedicines, 13(2), 490.
https://doi.org/10.3390/biomedicines13020490
